U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07121920) titled 'Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD' on Aug. 12.
Brief Summary: This study aims to test the overall hypothesis that the membrane tissue binding capacity of cytokines in the biopsied tissue of patients with Inflammatory Bowel Disease (IBD) is predictive of/strongly correlated to clinical response/outcomes observed.
The key questions under investigation are:
Aim 1: To assess the fluorescent signal intensity at baseline (control antibody with control biopsy and control antibody with IBD biopsy).
Aim 2: To characterize the cellular landscape by surveying surface marker...